Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) EPS (Basic): 2013-2018

Historic EPS (Basic) for Astria Therapeutics (ATXS) over the last 6 years, with Dec 2018 value amounting to -$5.12.

  • Astria Therapeutics' EPS (Basic) rose 64.14% to -$0.85 in Q4 2018 from the same period last year, while for Dec 2018 it was -$5.79, marking a year-over-year increase of 6.76%. This contributed to the annual value of -$5.12 for FY2018, which is 59.43% up from last year.
  • Latest data reveals that Astria Therapeutics reported EPS (Basic) of -$5.12 as of FY2018, which was up 59.43% from -$12.62 recorded in FY2017.
  • Astria Therapeutics' EPS (Basic)'s 5-year high stood at -$2.22 during FY2016, with a 5-year trough of -$51.56 in FY2014.
  • Over the past 3 years, Astria Therapeutics' median EPS (Basic) value was -$5.12 (recorded in 2018), while the average stood at -$6.65.
  • In the last 5 years, Astria Therapeutics' EPS (Basic) surged by 92.13% in 2015 and then crashed by 468.47% in 2017.
  • Astria Therapeutics' EPS (Basic) (Yearly) stood at -$51.56 in 2014, then spiked by 92.13% to -$4.06 in 2015, then surged by 45.32% to -$2.22 in 2016, then crashed by 468.47% to -$12.62 in 2017, then soared by 59.43% to -$5.12 in 2018.